EFFECTS OF CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS OPERATED FORGASTRIC CANCER
- Authors: Olzhayev S.T1, Shoykhet Y.N.2, Lazarev A.F3
-
Affiliations:
- Almaty Regional Oncological Center
- Altai State Medical University
- Altai Branch of the N.N. Blokhin Russian Cancer Research Center
- Issue: Vol 22, No 2 (2017)
- Pages: 76-79
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40356
- DOI: https://doi.org/10.18821/1028-9984-2017-22-2-76-79
- ID: 40356
Cite item
Full Text
Abstract
The purpose of the study is the assessment of the effect of the correction of endothelial dysfunction on the indices of the function of vascular endothelium and hemostasis system in gastric cancer patients. There were examined 102 patients with advanced gastric cancer at the II (T1-3N1-2M0) and III (T2-4N2-3M0) clinical stage. The control group included 40 healthy subjects matched by age and gender. We evaluated the relationship degree of endothelial dysfunction and its correction results with the outcomes of the treatment after surgery. Patients were divided into 2 groups - the standard of reference (55) and the additional use of means of vascular endothelial function correction (47 patients). Compared group had no significant difference in general and oncological parameters. Additional treatment included the use of the drug L-arginine at a dose of 1.0 g / day in combination with an ACE inhibitor. Statistical analysis envisaged the determination of the degree of significance of differences between groups of indices on the method of Mann-Whitney. As an boundary indication of the presence of the statistical significance there was accepted p < 0.05. There was revealed the presence of significant differences in the degree of damage (the number of circulating endothelial cells) and violations of the functional state of the vascular endothelium in patients exposed standard (main group) treatment and the use of other methods of correction of endothelial dysfunction. In the study group there was also achieved significant correction of hemostasis.
Full Text
##article.viewOnOriginalSite##About the authors
S. T Olzhayev
Almaty Regional Oncological Center
Email: s.olzhayev20@gmail.com
канд. мед. наук, директор диспансера; 050019, Республика Казахстан, г.Алматы, ул. Демченко, д. 83. Almaty, 050019, Republic of Kazakhstan
Ya. N. Shoykhet
Altai State Medical UniversityBarnaul, 656038, Russian Federation
A. F Lazarev
Altai Branch of the N.N. Blokhin Russian Cancer Research CenterBarnaul, 656049, Russian Federation
References
- Triplett D.A. Antiphospholipid antibodies: proposed mechanisms of action. Am. J. Reprod. Immunol. 1992; 28(3-4): 211-5.
- Murdaca G., Colombo B.M., Cagnati P., Gulli R., Spanò F., Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis. 2012; 224(2): 309-17.
- Gutiérrez E., Flammer A.J., Lerman L.O., Elízaga J., Lerman A., Fernández-Avilés F. Endothelial dysfunction over the course of coronary artery disease. Eur. Heart J. 2013; 34(41): 3175-81.
- Hall M., Gourley C., McNeish I., Ledermann J., Gore M., Jayson G. et al. Targeted anti-vascular therapies for ovarian cancer: current evidence. Br. J. Cancer. 2013; 108(2): 250-8.
- Bory M. Detection of circulating cells: a new diagnostic test of angina at rest. Arch. Mal. Coeur. 1995; 88(12): 1827-31.
- Карпюк В.Б., Черняк Ю.С., Шубич М.Г. Лабораторные критерии оценки NO-синтетазной активности у больных сосудистыми заболеваниями головного мозга. Клин. лаб.диагн.1998; (8): 40.
- Кишкун А.А. Руководство по лабораторным методам диагностики. М.: Гэотар-Медиа; 2009: 316-7.
- Celermajer D., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340: 1111-5.
- Ройтман Е.В., Морозов К.М., Андрианова М.Ю., Колесникова И.М. Вопросы выбора антитромботических препаратов. II. Взгляд на выбор низкомолекулярных гепаринов в онкологии. Тромбоз, гемостаз и реология. 2014; 60(4): 23-6.